stella
beta
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager — Stella
Home
/
Multiple Myeloma Refractory
/
View on ClinicalTrials.gov
Recruiting
Back to Multiple Myeloma Refractory trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
Canada
Centre Intégré de Cancérologie, Québec, Quebec